4//SEC Filing
Lewis-Hall Freda C 4
Accession 0000950170-25-048900
CIK 0001782223other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 9:02 AM ET
Size
5.3 KB
Accession
0000950170-25-048900
Insider Transaction Report
Form 4
Lewis-Hall Freda C
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31$0.98/sh+36,979$36,239→ 36,979 totalExercise: $0.98Exp: 2035-03-31→ Common Stock (36,979 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001437909
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 9:02 AM ET
- Size
- 5.3 KB